Skin Associates (Holdings) Limited Filleted accounts for Companies House (small and micro)

SKIN ASSOCIATES (HOLDINGS) LIMITED - Company Information

0 false false false false false false false false false true false false false false false false No description of principal activity 2022-03-01 Sage Accounts Production Advanced 2021 - FRS102_2021 200 200 200 xbrli:pure xbrli:shares iso4217:GBP 08756662 2022-03-01 2023-02-28 08756662 2023-02-28 08756662 2022-02-28 08756662 bus:Director3 2022-03-01 2023-02-28 08756662 core:WithinOneYear 2023-02-28 08756662 core:WithinOneYear 2022-02-28 08756662 core:ShareCapital 2023-02-28 08756662 core:ShareCapital 2022-02-28 08756662 core:RetainedEarningsAccumulatedLosses 2023-02-28 08756662 core:RetainedEarningsAccumulatedLosses 2022-02-28 08756662 core:CostValuation core:Non-currentFinancialInstruments 2023-02-28 08756662 core:Non-currentFinancialInstruments 2023-02-28 08756662 core:Non-currentFinancialInstruments 2022-02-28 08756662 bus:Director3 2022-02-28 08756662 bus:Director3 2021-02-28 08756662 bus:SmallEntities 2022-03-01 2023-02-28 08756662 bus:AuditExemptWithAccountantsReport 2022-03-01 2023-02-28 08756662 bus:FullAccounts 2022-03-01 2023-02-28 08756662 bus:SmallCompaniesRegimeForAccounts 2022-03-01 2023-02-28 08756662 bus:PrivateLimitedCompanyLtd 2022-03-01 2023-02-28

COMPANY REGISTRATION NUMBER: 08756662

SKIN ASSOCIATES (HOLDINGS) LIMITED

FILLETED UNAUDITED FINANCIAL STATEMENTS

28 February 2023

SKIN ASSOCIATES (HOLDINGS) LIMITED

STATEMENT OF FINANCIAL POSITION

28 February 2023

	2023		2022
Note	£	£	£

Fixed assets

Investments	4		200	200

Current assets

Debtors	5	100		100

Creditors: amounts falling due within one year	6	1,724		1,724
		-------		-------
Net current liabilities			1,624	1,624
			-------	-------
Total assets less current liabilities			( 1,424)	( 1,424)
			-------	-------
Net liabilities			( 1,424)	( 1,424)
			-------	-------

Capital and reserves

Called up share capital	100	100
Profit and loss account	( 1,524)	( 1,524)
	-------	-------
Shareholders deficit	( 1,424)	( 1,424)
	-------	-------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.

For the year ending 28 February 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

SKIN ASSOCIATES (HOLDINGS) LIMITED

STATEMENT OF FINANCIAL POSITION (continued)

28 February 2023

These financial statements were approved by the board of directors and authorised for issue on 28 July 2023 , and are signed on behalf of the board by:

Mrs F C Dilazzaro

Director

Company registration number: 08756662

SKIN ASSOCIATES (HOLDINGS) LIMITED

NOTES TO THE FINANCIAL STATEMENTS

YEAR ENDED 28 FEBRUARY 2023

1. General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 168 Church Road, Hove, East Sussex, BN3 2DL, England.

2. Statement of compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Going concern

The financial statements have been prepared under the going concern basis which assumes that the company will continue in operational existence for the foreseeable future. The validity of this assumption depends upon the continuing support of the company's connected companies and directors.

If the company were unable to continue in operational existence for the foreseeable future, adjustments would have to be made to reduce the balance sheet values of the assets to their recoverable amounts and to provide for further liabilities that might arise. The directors believe that it is appropriate for the financial statements to be prepared on the going concern basis.

Judgements and key sources of estimation uncertainty

The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

Investments

Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.

Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.

Financial instruments

Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

4. Investments

	Shares in group undertakings
	£
Cost
At 1 March 2022 and 28 February 2023	200
	----
Impairment
At 1 March 2022 and 28 February 2023	–
	----

Carrying amount
At 28 February 2023	200
	----
At 28 February 2022	200
	----

5. Debtors

	2023	2022
	£	£
Other debtors	100	100
	----	----

6. Creditors: amounts falling due within one year

	2023	2022
	£	£
Amounts owed to group undertakings and undertakings in which the company has a participating interest	724	724
Other creditors	1,000	1,000
	-------	-------
	1,724	1,724
	-------	-------

7. Directors' advances, credits and guarantees

During the year the directors entered into the following advances and credits with the company:

	Balance brought forward and outstanding
	2023	2022
	£	£
Mrs F C Dilazzaro	100	100
	----	----

8. Related party transactions

The company was under the control of Mr F Dilazzaro throughout the current period. Mr F Dilazzaro is the managing director and majority shareholder. The company holds 100% of the share capital of Skin Associates Limited and Skin Associates (Medical) Limited. As at 28th February 2023 the directors owed the company £100 (2020 - £100). As at 28th February 2023 the company owed £60,723 (2022 - £34,723)to Skin Associates Limited. As at 28th February 2023 the company was owed £60,000 by Skin Associates (Medical) Limited (2022 - £34,000).